Statin Therapy Questioned for Primary Prevention

Researchers reanalyzed 11 pacebo-controlled trials of statin use in more than 65,000 high-risk patients without cardiovascular disease at baseline. While LDL levels were lower in the statin users than the placebo, there was no difference in all-cause mortality. Other investigators re-looked at the JUPITER trial which claimed a large benefit from one of the statins and determined it was flawed due to insufficient length and financial ties to the manufacturer.

PositiveTip: Medications should never be used as substitutes for true primary preventative measures such as healthy lifestyle choices and activities.